WINDSURF: Wetsuit and Life Jacket Induced Effects on Spirometry and VO2 in Windsurfers

Sponsor
University Hospital, Brest (Other)
Overall Status
Completed
CT.gov ID
NCT03440294
Collaborator
(none)
34
1
2
13.8
2.5

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate the effect of wearing both neoprene suit and life jacket on respiratory capacities at rest and cardiopulmonary capacities during exercise in windsurfers.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: resting standard spirometry
  • Diagnostic Test: maximum exercise testing
N/A

Detailed Description

Windsurfers will perform resting spirometry and exercise test on cycle ergometer until exhaustion in two conditions: with or without equipment. The investigators will measure Forced Vital Capacity, FEV1 peak flow at rest and oxygen uptake, carbon dioxide consumption, ventilation at each step of the incremental exercise and at exhaustion.

Study Design

Study Type:
Interventional
Actual Enrollment :
34 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Étude de l'Effet de la Combinaison néoprène et de l'équipement Individuel de Flottaison Sur la Fonction Respiratoire de Repos et Les capacités à l'Effort Chez Les véliplanchistes : étude WINDSURF
Actual Study Start Date :
Feb 22, 2018
Actual Primary Completion Date :
Apr 18, 2019
Actual Study Completion Date :
Apr 18, 2019

Arms and Interventions

Arm Intervention/Treatment
Other: with neoprene suit and life jacket

Realization of the following examinations WITH neoprene suit and life jacket : resting standard spirometry maximum exercise testing. No drug and no placebo will be used in this arm.

Diagnostic Test: resting standard spirometry
The subject (seated, bust straightened) should perform, after a slow and maximum inspiration, a forced and complete exhalation followed by a new inspiration to the total lung capacity.

Diagnostic Test: maximum exercise testing
Incremental exercise on cycle ergometer with 100W start for men (80W for women) for 4 minutes as part of the warm-up. Then, step increment of a 50W power for men (40W for women) lasting 2 minutes each.

Other: without neoprene suit and life jacket

Realization of the following examinations WITHOUT neoprene suit and life jacket : resting standard spirometry maximum exercise testing. No drug and no placebo will be used in this arm.

Diagnostic Test: resting standard spirometry
The subject (seated, bust straightened) should perform, after a slow and maximum inspiration, a forced and complete exhalation followed by a new inspiration to the total lung capacity.

Diagnostic Test: maximum exercise testing
Incremental exercise on cycle ergometer with 100W start for men (80W for women) for 4 minutes as part of the warm-up. Then, step increment of a 50W power for men (40W for women) lasting 2 minutes each.

Outcome Measures

Primary Outcome Measures

  1. Forced Vital Capacity (FVC in L) at rest. [1 day]

    spirometry at rest

Secondary Outcome Measures

  1. Forced Expiratory Volume [1 day]

    FEV1 (in L)

  2. Peak Flow [1 day]

    PF (peak flow in L/s)

  3. mean flow rates [1 day]

    mean expiratory flow rates in L/ s at 75%, 50% and 25% of FVC (MEF 75, MEF 50, MEF 25).

  4. maximal ventilation [1 day]

    VE (ventilation in L/min)

  5. carbon dioxide production [1 day]

    VCO2 ( in L/min)

  6. oxygen consumption [1 day]

    VO2 ( in L/min)

  7. tidal volume [1 day]

    VT (in L)

  8. breathing frequency [1 day]

    RF (in breaths/min)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Male or female aged 18 to 35

  • Do not contraindicate any of the investigations in the study

  • Being affiliated to a social security system

  • free, informed and written consent

  • Have already performed a cardiopulmonary exercise test without any electrocardiographic abnormality

  • Subject practicing windsurfing (whatever the level of practice (leisure or competition))

Exclusion Criteria:
  • Subjects < 18 years old

  • Pregnant woman

  • Inability to consent

  • Taking any of the following: oral or inhaled Beta 2 short-acting or long-acting mimetics, oral or inhaled corticosteroids, oral anti-leukotrienes.

  • Abnormalities in the resting ECG pattern

Contacts and Locations

Locations

Site City State Country Postal Code
1 University hospital Brest France 29200

Sponsors and Collaborators

  • University Hospital, Brest

Investigators

  • Principal Investigator: Marie Agnes Giroux-Metges, Pr, CHRU de Brest

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Brest
ClinicalTrials.gov Identifier:
NCT03440294
Other Study ID Numbers:
  • 29BRC17.0233
First Posted:
Feb 22, 2018
Last Update Posted:
May 7, 2019
Last Verified:
May 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Brest

Study Results

No Results Posted as of May 7, 2019